Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 6Breast 6Other hematologic neoplasm 4Thoracic 3Lymphoid 3Other solid neoplasm 2Other 2Genitourinary 2Other neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 2Motor Activity 1Colorectal Neoplasms 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 123Radiotherapy 117Sunitinib 112Cisplatin 103Leuprolide 98pembrolizumab 96Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 66acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Cyclophosphamide 44Radiosurgery 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Exercise Test × Genitourinary × Clear all
NCT06016725 2026-01-02

E-PROOF

Ohio State University Comprehensive Cancer Center

Phase NA Completed
75 enrolled 27 charts
GastrointestinalGenitourinary

Prostatic Neoplasms, Colorectal Neoplasms

NCT02435472 2025-04-11

ASX

University of California, San Francisco

Phase NA Completed
104 enrolled
Genitourinary

Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡